• Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies
  • Gram Stain with the Nugent Scoring
  • Cryptococcosis
  • Ropivacaine, Serum
  • Immunoglobulin M (IgM), Serum
  • Nicotine replacement therapy
  • Dexedrine (Dextroamphetamine), Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
Medical Test

Interpretation
Access to MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection is restricted.
Loading...